Patents Assigned to HIFIBIO, INC.
  • Anti-galectin-9 antibody and uses thereof
    Patent number: 12649794
    Abstract: The invention provides humanized monoclonal antibodies against Gal9, and method of using the antibodies to treat cancer, including combination therapy with antagonists of the PD-1/PD-L1 immune checkpoint.
    Type: Grant
    Filed: January 6, 2021
    Date of Patent: June 9, 2026
    Assignee: HIFIBIO, INC.
    Inventors: Germain Margall Ducos, Rachel Pacherie, Nicola Arturo Aldo Beltraminelli, Francisco Adrian, Liang Schweizer, Muriel David, Yun-Yueh Lu
  • ANTI-CCR8 ANTIBODIES AND USES THEREOF
    Publication number: 20250019451
    Abstract: Anti-CCR8 antibodies and antigen-binding fragments thereof are described herein. Also described herein are nucleic acids encoding the anti-CCR8 antibodies and antigen-binding fragments thereof, compositions comprising the anti-CCR8 antibodies and antigen-binding fragments thereof, and methods of producing and using the anti-CCR8 antibodies and antigen-binding fragments thereof for treating or preventing cancer in a subject in need thereof.
    Type: Application
    Filed: August 19, 2022
    Publication date: January 16, 2025
    Applicant: HIFIBIO, INC.
    Inventors: Julie PRIGENT, Nicola Arturo Aldo BELTRAMINELLI, Sami ELLOUZE, Francisco ADRIAN, Liang SCHWEIZER, Yun-Yueh LU, Ross Bane FULTON